Zhiru Zeng
Hangzhou, 310009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Safety and efficacy of low-dose, cord blood-derived CD19 CAR-NK cells with 4-1BB co-stimulation in refractory systemic lupus erythematosus.
Journal: Med (New York, N.Y.)
Published: March 12, 2026
Emerging roles of mechanically activated ion channels in autoimmune disease.
Journal: Autoimmunity reviews
Published: January 21, 2025
The key role of matrix stiffness in colorectal cancer immunotherapy: mechanisms and therapeutic strategies.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: June 11, 2024
A rare case of IgG4-related disease masquerading as periurethral malignancy and review of the literature.
Journal: Frontiers in immunology
Published: October 23, 2022
FAIM Enhances the Efficacy of Mesenchymal Stem Cell Transplantation by Inhibiting JNK-Induced c-FLIP Ubiquitination and Degradation.
Journal: Stem cells international
Published: July 15, 2022
PTP1B Inhibition Improves Mitochondrial Dynamics to Alleviate Calcific Aortic Valve Disease Via Regulating OPA1 Homeostasis.
Journal: JACC. Basic to translational science
Published: January 13, 2022
SRT1720 Pretreatment Promotes Mitochondrial Biogenesis of Aged Human Mesenchymal Stem Cells and Improves Their Engraftment in Postinfarct Nonhuman Primate Hearts.
Journal: Stem cells and development
Published: February 11, 2021
TPP1 Enhances the Therapeutic Effects of Transplanted Aged Mesenchymal Stem Cells in Infarcted Hearts via the MRE11/AKT Pathway.
Journal: Frontiers in cell and developmental biology
Published: July 28, 2020
Leptin increases mitochondrial OPA1 via GSK3-mediated OMA1 ubiquitination to enhance therapeutic effects of mesenchymal stem cell transplantation.
Journal: Cell death & disease
Published: October 15, 2017
SRT1720 promotes survival of aged human mesenchymal stem cells via FAIM: a pharmacological strategy to improve stem cell-based therapy for rat myocardial infarction.
Journal: Cell death & disease
Published: October 04, 2016
The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis.
Journal: Oncotarget
Published: June 14, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026